Helsinki – January 15, 2018 – MediSapiens, a leading Finnish developer and provider of genomic, biomedical and healthcare data solutions, has joined The Pistoia Alliance, a global, non-profit alliance of life science companies, vendors, publishers and academic groups that work together to lower barriers to innovation.
Founded in 2009 by representatives of AstraZeneca, GSK, Novartis and Pfizer, the alliance today has nearly 70 paying member organizations. Some of the alliance’s key activities are pre-competitive projects, where partners join their forces to establish best practices and technology pilots. Successful initiatives have included The HELM Project and the launch of the Chemical Safety Library Service.
“We are very pleased to welcome MediSapiens into The Pistoia Alliance, and look forward to working with them to achieve our goal of lowering barriers to innovation in the life science industry,” commented Dr. Steve Arlington, President of The Pistoia Alliance. “The world of life sciences R&D continues to change rapidly – and sharing, partnering and collaborating will be essential to increased innovation. As our membership continues to grow, our projects and initiatives will be vital in fostering this collaborative mind-set and leading to new breakthroughs.”
With nearly a decade of experience working in the life science software industry, MediSapiens will be able to offer its expertise in scientific, technological and bioinformatics developments to The Pistoia Alliance innovation projects. By joining the alliance, MediSapiens will have the opportunity to collaborate with industry peers, thus contributing to the development of the worldwide research community.
“We are excited to be a part of The Pistoia Alliance and we look forward to being an active member in the workgroups,” says Henrik Edgren, Chief Scientific Officer of MediSapiens. “Joining the Pistoia Alliance enables us to follow and influence the latest developments in data sharing and efficient collaboration in life sciences, for instance in our work with implementing ontologies effectively.”
About the Pistoia Alliance
The Pistoia Alliance is a not-for-profit alliance of life science companies, vendors, publishers, and academic groups that work together to lower barriers to innovation in R&D. Its projects transform R&D innovation through pre-competitive collaboration, bring together key constituents to identify the root causes that lead to R&D inefficiencies, and develop best practices and technology pilots to overcome common obstacles. Pistoia Alliance members collaborate as equals on open projects that generate significant value for the worldwide life sciences community.
MediSapiens Ltd. is a Bio-IT and bioinformatics company specialized in pharmaceutical research and translational genomics, providing life science and biomedical companies and research organizations with tools that help them manage and interpret large genomic, biomedical and clinical data sets. Established in 2009 and based in Helsinki, Finland and Cambridge, Massachusetts, MediSapiens creates intuitive software platforms to manage, integrate, and visualize complex multi-dimensional datasets, such as genomic sequencing data. The company’s goal is to drive medicine forward by developing tools that provide scientists with a way to quickly analyze and visualize vast amounts of data and turn it into knowledge that fuels innovation. For further information, please visit medisapiens.com.
CSO, MediSapiens Ltd.
Contact Pistoia Alliance
Spark Communications Ltd
+44 207 436 0420